Immunotherapy in advanced, KRAS G12C-mutant non-small-cell lung cancer: current strategies and future directions.
Immunotherapy in advanced, KRAS G12C-mutant non-small-cell lung cancer: current strategies and future directions. Ther Adv Med Oncol. 2025; 17:17588359251323985.